Adverse events following immunization of ChAdOx1 nCoV-19 vaccine among healthcare workers of a medicine-teaching institution of North India.

OBJECTIVE

This study sought to assess the prevalence of adverse events following immunization (AEFI) and factors associated with AEFI of the ChAdOx1 nCoV-19 vaccine (Covishield) among healthcare workers (HCW) of a medicine-teaching institution of North India.

MATERIALS AND METHODS

A cross-sectional study was conducted in the months of June and July 2021 among HCW ( = 203) of 18 years and above, vaccinated with at least the first dose of Covishield. A semi-structured, prevalidated, and pretested questionnaire was used to collect information through an interview schedule. The questionnaire was divided into five sections: the sociodemographic profile, behavioral characteristics, past medical history, COVID-19 awareness, and past infection and COVID-19 vaccine related information. Chi-squared test was applied to check the association of different factors with AEFI.

RESULTS

In our study, 73.89% of participants suffered from at least one AEFI after the first dose of the vaccine, while 48.66% had at least one AEFI after the second dose. Females reported significantly high AEFI for both doses ( = 0.001, 0.000). We found a significant association between the occurrence of AEFI and occupation (first dose = 0.015), substance abuse (first dose = 0.002), diet (first dose = 0.016), and allergy (first dose = 0.027). Other significant findings were headaches among HCW ≥40 years of age (dose = 0.034) and systemic AEFI in participants with comorbidity (first dose = 0.020).

CONCLUSION

More AEFI were reported after the first dose as compared to the second dose. AEFI were more among females after both the doses. Occupation, substance use, diet, and history of allergy were significantly associated with AEFI.